{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:35:24Z","timestamp":1788554124143,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jpba.2023.115740","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:14:43Z","timestamp":1695266083000},"page":"115740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine"],"prefix":"10.1016","volume":"236","author":[{"given":"Jaime","family":"Mill\u00e1n-Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Vitagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunata","family":"Mondella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-591X","authenticated-orcid":false,"given":"Roberto","family":"Mandrioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roccaldo","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3322-4807","authenticated-orcid":false,"given":"Toma\u017e","family":"Vovk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-8284","authenticated-orcid":false,"given":"Soledad","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Boaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-3759","authenticated-orcid":false,"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Petio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9310-4957","authenticated-orcid":false,"given":"Michele","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-9461","authenticated-orcid":false,"given":"Laura","family":"Mercolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115740_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpba.2023.115740_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/brainsci13030414","article-title":"Application of antipsychotic drugs in mood disorders","volume":"13","author":"Rybakowski","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpba.2023.115740_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/cap.2018.0037","article-title":"A focused review on the treatment of pediatric patients with atypical antipsychotics","volume":"28","author":"Lee","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpba.2023.115740_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/TCRM.S35137","article-title":"A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia","volume":"9","author":"Caccia","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jpba.2023.115740_bib5","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.2147\/NDT.S335332","article-title":"Cariprazine in three special different areas: a real-world experience","volume":"17","author":"Gesi","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpba.2023.115740_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bja.2021.49","article-title":"Partial agonists of dopamine receptors: Mechanisms and clinical effects of aripiprazole, brexpiprazole and cariprazine","volume":"29","author":"Cookson","year":"2023","journal-title":"BJPsych Adv."},{"key":"10.1016\/j.jpba.2023.115740_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12991-020-00305-3","article-title":"Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel","volume":"19","author":"Fagiolini","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jpba.2023.115740_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpba.2023.115740_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4155\/bio.15.123","article-title":"Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs","volume":"7","author":"Mercolini","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2023.115740_bib10","series-title":"\u201cFrontiers in Clinical Drug Research \u2013 Diabetes and Obesity\u201d","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/9781681087535120050003","article-title":"Chapter 1. metabolic syndrome in schizophrenia: focus on the role of antipsychotic medications and indications for therapeutic drug monitoring (TDM) methods","volume":"5","author":"Mandrioli","year":"2020"},{"key":"10.1016\/j.jpba.2023.115740_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.chroma.2020.461731","article-title":"A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring","volume":"1635","author":"Tey","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115740_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4155\/bio-2019-0041","article-title":"Microsampling: considerations for its use in pharmaceutical drug discovery and development","volume":"11","author":"Spooner","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2023.115740_bib13","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1039\/D0AN01039A","article-title":"Assessment of capillary volumetric blood microsampling for the analysis of central nervous system drugs and metabolites","volume":"145","author":"Protti","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2023.115740_bib14","first-page":"1","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londh","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib15","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115740_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: Current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial: Volumetric absorptive microsampling (VAMS)","volume":"2046","author":"Protti","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2023.115740_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2020.113384","article-title":"Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs","volume":"188","author":"Marasca","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jchromb.2016.12.038","article-title":"Dried haematic microsamples and LC-MS\/MS for the analysis of natural and synthetic cannabinoids","volume":"1045","author":"Protti","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2023.115740_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FTD.0000000000000884","article-title":"Microsampling devices for routine therapeutic drug monitoring-are we there yet?","volume":"43","author":"Morgan","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2023.115740_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","article-title":"Alternative sampling devices to collect dried blood microsamples: state-of-the-art","volume":"43","author":"Delahaye","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2023.115740_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14070627","article-title":"therapeutic drug monitoring of antiseizure medications using volumetric absorptive microsampling: where are we?","volume":"14","author":"D\u2019Urso","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2023.115740_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.794609","article-title":"Dried volumetric microsampling approaches for the therapeutic drug monitoring of psychiatric patients undergoing clozapine treatment","volume":"13","author":"Marasca","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2023.115740_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonz\u00e1lez","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib25","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00216-018-0866-4","article-title":"Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs","volume":"410","author":"Velghe","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2023.115740_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jpba.2017.07.033","article-title":"Volumetric adsorptive microsampling-liquid chromatography tandem mass spectrometry assay for the simultaneous quantification of four antibiotics in human blood: Method development, validation and comparison with dried blood spot","volume":"145","author":"Barco","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpba.2018.01.043","article-title":"Determination of oxycodone and its major metabolites in haematic and urinary matrices: comparison of traditional and miniaturised sampling approaches","volume":"152","author":"Protti","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpba.2007.12.016","article-title":"Sensitive LC\u2013MS\/MS methods for the quantification of RGH-188 and its active metabolites, desmethyl- and didesmethyl-RGH-188 in human plasma and urine","volume":"48","author":"M\u00e9sz\u00e1ros","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115740_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","article-title":"Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents","volume":"59","author":"Gyerty\u00e1n","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jpba.2023.115740_bib30","unstructured":"Food and Drug Administration, Bioanalytical Method Validation Guidance for Industry, 2018. Available at \u3008https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf\u3009 (Last Accessed on 30 April 2023)."},{"key":"10.1016\/j.jpba.2023.115740_bib31","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH Harmonised Guideline M10 - Bioanalytical Method Validation and Study Sample Analysis, 2022. Available at: \u3008https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf\u3009 (Last Accessed on 30 April 2023)."},{"key":"10.1016\/j.jpba.2023.115740_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2023.115740_bib33","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/molecules25051046","article-title":"Blood and plasma volumetric absorptive microsampling (VAMS) coupled to LC-MS\/MS for the forensic assessment of cocaine consumption","volume":"25","author":"Mandrioli","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115740_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2016.02.015","article-title":"LC-MS\/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples","volume":"123","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523005095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523005095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:35:33Z","timestamp":1760002533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523005095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"alternative-id":["S0731708523005095"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115740","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115740"}}